GlassScriptPhysician profile
Mary E Vitale
NPI 1760823546
$3,660.90
in general payments reported to CMS, 2019-2025
39 companies · $549 in 2025
The $549 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,001 · 2022: $640 · 2023: $723 · 2024: $748 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,019.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $713.81 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $415.35 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $299.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $283.14 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $236.13 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.01 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $144.91 | 2021-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Lilly USA, LLC | $132.66 | 2021-2025 | Jardiance, Zepbound |
| Ironwood Pharmaceuticals, INC | $125.00 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.60 | 2021-2023 | |
| Almatica Pharma LLC | $103.82 | 2022-2023 | Loreev Xr, Gralise, Sertraline Hcl |
| Exact Sciences Corporation | $100.14 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $79.79 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $74.71 | 2021-2025 | Otezla, Repatha, Repatha |
| Esperion Therapeutics, INC. | $72.07 | 2021-2024 | Nexletol |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Vitale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.